PBM Critics Increasingly Take Their Grievances to Court
As scrutiny on PBMs continues, various stakeholders are turning to the legal system to challenge the business practices of major firms.
Centene Corp. has been the target of the most litigation, having now reached settlements with nine state attorneys general over allegations that its PBM subsidiary Envolve overcharged those states’ Medicaid programs for prescription drugs, according to a filing with the Securities and Exchange Commission. The company has set aside $1.25 billion to fund those settlements and potential future lawsuits, and it is in the process of restructuring its PBM holdings.
© 2025 MMIT